ICIS Global Top 100 Chemical Companies: Who Is Truly Strong and Who Is Just Bloated? What Will Define Competitive Advantage in the Chemical Industry’s Future?

The two companies in question operate fundamentally different businesses—differing in asset intensity, cyclical exposure, customer relationships, and pricing power. Sales revenue only indicates which company is larger—not which is stronger. IV. The global chemical industry is not uniformly deteriorating; rather, it is undergoing accelerating divergence. Among the 100 companies on the ICIS list, 91 disclosed EBIT figures: 53 posted operating profit margins below 5%, 26 reported operating losses, and 20 maintained double-digit EBIT margins. The global chemical industry—despite its overall sluggishness—is experiencing severe polarization. Covestro reported a $407 million loss; Westlake Chemical, a $1.426 billion loss; Celanese, $786 million; Versalis, $1.672 billion in operating losses; and FMC, $1.647 billion. In contrast, Shin-Etsu, NewMarket, and Givaudan continue to demonstrate robust profit conversion capabilities. If all companies declined simultaneously, it might simply reflect a cyclical downturn. But within the same cycle, some firms suffer massive losses while others sustain operating margins above 20%—making product mix, cost positioning, customer switching costs, technological barriers, and capital intensity critically important. The cycle hasn’t disappeared; instead, it has magnified previously subtle differences among business models. V. What matters most is not pursuing 'high-end' products per se—but the quality of the product portfolio. Commodity chemicals face persistent margin pressure, whereas specialty chemicals show visible profitability—leading many to define strategic direction simply as 'moving upmarket'. Yet, summarizing the situation as 'commodity = bad, specialty = good' is an oversimplification and insufficient as a commercial judgment. A commodity chemical enterprise with low-cost feedstocks, highly efficient assets, and a globally leading cost curve can generate excellent returns on capital. Conversely, a so-called specialty chemical firm—whose products lack meaningful barriers to entry, whose customers face negligible switching costs, and into which competitors flood easily—may earn little or no profit. Thus, what truly matters is not merely whether products are commodity or specialty, but the quality of the product portfolio. Can a chemical company’s portfolio weather cycles? How much pricing power does it command? How much capital does it tie up? How long can its technological moats endure? What is its future market growth potential? Do customers incur meaningful costs when switching suppliers? Only by integrating these factors can we assess whether sales translate into profits—and whether those profits convert into sustainable, long-term returns. From this perspective, what truly merits emulation in Wanhua’s case is not merely its polyurethane business—but its ability to integrate diverse segments—including polyurethanes, petrochemicals, new materials, and battery materials—into a more stable, higher-return business system than any single product line could deliver. Capital allocation capability is the ultimate pursuit for large-scale chemical enterprises—though its results will only become evident years later. VI. The global chemical industry is shifting—from capacity expansion capability to capital allocation capability. Of the 76 companies in the ICIS ranking that disclosed year-on-year changes in capital expenditures (Capex), 44 reduced Capex, 31 increased it, and 1 remained essentially flat. Even industry leaders are cutting back: nearly 60% of firms—including top-tier giants—are scaling down capital spending. In 2025, BASF’s Capex stands at $5.007 billion—a 31.2% decline year-on-year; Dow’s fell 15.7%; SABIC’s dropped 30.7%; and ExxonMobil’s chemical Capex decreased by 8.4%.

How is the chlor-alkali chemical industry faring? What is its current development status?

Epichlorohydrin industry | Caustic soda industry | PVC industry Core products: caustic soda, liquid chlorine, PVC, VCM, epichlorohydrin; Core competencies: electricity cost, salt resource availability, and vertical integration across upstream and downstream operations. China: Accounts for nearly half of global caustic soda capacity; Northwest China relies predominantly on calcium carbide-based PVC production; East China favors ethylene-based routes; environmental protection and energy consumption regulations are stringent, constraining new capacity additions. North America and Europe: Predominantly adopt ethylene-based PVC routes, benefiting from lower hydrocarbon feedstock costs; actively advancing electrolyzer-based green electricity transition—carbon reduction is a key strategic priority. Formosa Plastics (Taiwan): A major integrated player in the Asia-Pacific region; exports large volumes of ethylene-based PVC globally and holds a pivotal position in the global vinyls value chain. Olin and Westlake Chemical represent leading North American chlor-alkali and vinyls giants; INEOS and Solvay dominate Europe; Shin-Etsu and Formosa Plastics exemplify high-end, integrated players in the Asia-Pacific region; domestically, Zhongtai Chemical and Xinjiang Tianye lead China’s calcium carbide-based PVC sector.

RBC Capital Maintains 'Outperform' Rating on Westlake Chemical; Price Target Lowered to $74.00

Oct 13, 2026

RBC Capital maintained its 'Outperform' rating on Westlake Chemical but lowered the price target to $74.00 due to concerns over insider selling and unprofitability. Investors are advised caution despite the stock being identified as significantly undervalued.

GuruFocus

2026-01-04

Expectations for Global PVC Production Cuts Intensify

2026-02-24

Westlake Q4 Earnings Beat Amid Accelerated Cost Cutting

2026-03-02

Westlake Chemical Partners LP Filed Annual Report

2026-03-05

Westlake Chemical Partners Posts Full 2025 Annual Report Online

2026-03-13

Westlake Chemical Partners LP Files S-3 Shelf Registration Statement